Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Consolidative CD8 + Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation

Michael A. Spinner, MD, Lori S. Muffly, MD MS, Sally Arai, MD, Laura Johnston, MD, Everett H. Meyer, MD PhD, David B. Miklos, MD PhD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Judith A. Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Samuel Strober, MD, Robert Lowsky, MD

Blood (2017) 130 (Supplement 1): 2003.

https://doi.org/10.1182/blood.V130.Suppl_1.2003.2003

Published: 2017

Journal Articles

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

Michael A. Spinner, MD, Marcelo Fernandez Vina, PhD, Linda Elder, BA, Sally Arai, MD, Laura Johnston, MD, Everett Meyer, MD PhD, David Miklos, MD PhD, Lori Muffly, MD, Robert S. Negrin, MD, Judith Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Ginna G. Laport, MD, Samuel Strober, MD, Robert Lowsky, MD, Andrew R. Rezvani, MD

Blood (2016) 128 (22): 4669.

https://doi.org/10.1182/blood.V128.22.4669.4669

Published: 2016

Journal Articles

A Phase I Study of Donor Regulatory T Cells As Treatment for Steroid Dependent/Refractory Chronic Graft Versus Host Disease

Laura Johnston, MD, Randall Armstrong, Jeanette Baker, PhD, Bita Sahaf, Joanne Otani, Keri Tate, PhD, Cynthia Tudisco, Kevin Sheehan, PhD, Everett Meyer, MD PhD, David Miklos, MD PhD, Robert S. Negrin, MD

Blood (2016) 128 (22): 385.

https://doi.org/10.1182/blood.V128.22.385.385

Published: 2016

Journal Articles

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

Blood (2016) 128 (22): 505.

https://doi.org/10.1182/blood.V128.22.505.505

Published: 2016

Journal Articles

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

Blood (2015) 126 (23): 3232.

https://doi.org/10.1182/blood.V126.23.3232.3232

Published: 2015

Journal Articles

Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sézary Syndrome (SS)

Wen-Kai Weng, MD PhD, Randall Armstrong, Sally Arai, MD, Laura Johnston, MD, Ginna G. Laport, MD, Robert Lowsky, MD, David B. Miklos, Judith A. Shizuru, MD PhD, Jonathan E. Benjamin, Robert S. Negrin, MD, Sunil Reddy, MD, Lynn Million, MD, Richard T. Hoppe, MD, Youn H. Kim, MD

Blood (2014) 124 (21): 2544.

https://doi.org/10.1182/blood.V124.21.2544.2544

Published: 2014

Journal Articles

Early Infusion Of Donor-Derived CIK Cells As Consolidative Immunotherapy Following Non-Myeloablative Allogeneic Transplantation: Safety and Feasibility

Jonathan Benjamin, MD, PhD, Ginna G Laport, MD, Keri Tate, PhD, Leah Galvez, RN, Randall Armstrong, Kevin Sheehan, PhD, Sally Arai, MD, Robert Lowsky, MD, Laura Johnston, MD, David B. Miklos, MD, PhD, Judith Shizuru, PhD, MD, Wen-Kai Weng, MD, PhD, Robert Negrin, MD

Blood (2013) 122 (21): 899.

https://doi.org/10.1182/blood.V122.21.899.899

Published: 2013

Journal Articles

Non-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic Transplantation for Patients with Myelodysplastic Syndrome, Therapy-Related Myeloid Neoplasms, and Myeloproliferative Neoplasms.

Jonathan Benjamin, MD, PhD, Saurabh Chhabra, MD, Holbrook E Kohrt, MD, PhD, Ginna G Laport, MD, Sally Arai, MD, Laura Johnston, MD, David B Miklos, MD, PhD, Judith A. Shizuru, MD, PhD, Wen-Kai Weng, MD, PhD, Robert S. Negrin, MD, Robert Lowsky, MD

Blood (2012) 120 (21): 3087.

https://doi.org/10.1182/blood.V120.21.3087.3087

Published: 2012

Journal Articles

Impact of Day 28 Absolute Lymphocyte Count On Outcome of Hematopoietic Cell Transplant (HCT) in CR1 for Adult Patients with Acute Lymphoblastic Leukemia

Jonathan A Rose, MS, Tamara J. Dunn, MD, Michaela Liedtke, MD, Paul Elson, ScD, Matt Kalaycio, MD, Ed Copelan, MD, Ronald Sobecks, MD, Mikkael A. Sekeres, MD, MS, Sean Hobson, Laura Johnston, MD, Shawnda Tench, Sharisa Cross, Anjali Advani, MD

Blood (2012) 120 (21): 1472.

https://doi.org/10.1182/blood.V120.21.1472.1472

Published: 2012

Journal Articles

Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402

Corey Cutler, MD, MPH, FRCPC, Brent R. Logan, PhD, Ryotaro Nakamura, MD, Laura Johnston, MD, Sung W. Choi, M.D., David L Porter, MD, William J Hogan, MBBCh, Marcelo C Pasquini, MD, MS, Margaret L. MacMillan, MD, John R. Wingard, MD, Edmund K. Waller, MD, PhD, Stephan A. Grupp, MD, PhD, Philip L. McCarthy, MD, Juan Wu, MS, Zhenhuan Hu, MPH, Shelly L Carter, ScD, Mary M. Horowitz, MD, MS, Joseph H. Antin, MD

Blood (2012) 120 (21): 739.

https://doi.org/10.1182/blood.V120.21.739.739

Published: 2012

Journal Articles

A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease

George L. Chen, MD, Paul A. Carpenter, MD, Raewyn Broady, MBChB, FRACP, Tara B. Gregory, MD, Sally Arai, MD, Laura Johnston, MD, Mary E.D. Flowers, MD, Jan H. Beumer, PharmD, PhD, Jodie Mendolsohn, Xin Zhou, Spenser H. Perloff, Joanne M Otani, RN, MSN, David B Miklos, MD, PhD

Blood (2011) 118 (21): 1986.

https://doi.org/10.1182/blood.V118.21.1986.1986

Published: 2011

Journal Articles

Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial

Blood (2011) 118 (21): 1.

https://doi.org/10.1182/blood.V118.21.1.1

Published: 2011

Journal Articles

Chronic Graft-Versus-Host Disease Responds to Imatinib and Pre Transplant/Donor Anti-PDGFRA Antibodies Predict for Chronic Graft-Versus-Host Disease Development

George L. Chen, MD, Sally Arai, MD, Mary E.D. Flowers, MD, Joanne M Otani, RN, MSN, BS, Marc Coram, PhD, Alex McMillan, PhD, Judith A Shizuru, PhD, MD, Laura Johnston, MD, David Miklos, MD, PhD

Blood (2010) 116 (21): 2320.

https://doi.org/10.1182/blood.V116.21.2320.2320

Published: 2010

Journal Articles

A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis.

George L. Chen, MD, Sally Arai, MD, Mary E.D. Flowers, MD, Joanne Otani, RN, MSN, Ethan C. Cheng, Alex McMillan, PhD, Wen-Kai Weng, MD, PhD, Judith Shizuru, PhD, MD, Laura Johnston, MD, David Miklos, MD, PhD

Blood (2009) 114 (22): 3304.

https://doi.org/10.1182/blood.V114.22.3304.3304

Published: 2009

Journal Articles

Hematopoietic Stem Cell Transplantation following Reduced Intensity Conditioning for High Risk Patients with Paroxysmal Nocturnal Hemoglobinuria

Agata Mikolajewska, Haifa Kathrin Al-Ali, Nadezda Basara, Elliot Epner, Ernst Holler, Laura Johnston, MD, Dietger Niederwieser, Thoralf Lange

Blood (2008) 112 (11): 4407.

https://doi.org/10.1182/blood.V112.11.4407.4407

Published: 2008

Journal Articles

Membranous Glomerulonephritis and Nephrotic Syndrome as a Late Manifestation of Chronic Graft-Versus-Host Reaction Following Allogeneic Transplantation for Hematologic Malignancy.

Bashir Ahmad, MD, Barbara Stehr, NP, Laura Johnston, MD, Eileen Patricia Smith, MD, Auayporn P. Nademanee, MD, Pablo Miguel Parker, MD, Robert Negrin, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 2894.

https://doi.org/10.1182/blood.V108.11.2894.2894

Published: 2006

Journal Articles

Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Host Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin Confirm a Low Incidence of Graft Versus Host Disease (GVHD) and Retained Graft Anti-Tumor Activity.

Robert Lowsky, MD, Keith Stockerl-Goldstein, MD, Ginna Laport, MD, David Miklos, MD, Sally Arai, MD, Judith Shizuru, MD, Laura Johnston, MD, Karl Blume, MD, Robert Negrin, MD, Samuel Strober, MD

Blood (2006) 108 (11): 603.

https://doi.org/10.1182/blood.V108.11.603.603

Published: 2006

NARROW

Consolidative CD8 + Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

A Phase I Study of Donor Regulatory T Cells As Treatment for Steroid Dependent/Refractory Chronic Graft Versus Host Disease

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sézary Syndrome (SS)

Early Infusion Of Donor-Derived CIK Cells As Consolidative Immunotherapy Following Non-Myeloablative Allogeneic Transplantation: Safety and Feasibility

Non-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic Transplantation for Patients with Myelodysplastic Syndrome, Therapy-Related Myeloid Neoplasms, and Myeloproliferative Neoplasms.

Impact of Day 28 Absolute Lymphocyte Count On Outcome of Hematopoietic Cell Transplant (HCT) in CR1 for Adult Patients with Acute Lymphoblastic Leukemia

Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402

A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease

Chronic Graft-Versus-Host Disease Responds to Imatinib and Pre Transplant/Donor Anti-PDGFRA Antibodies Predict for Chronic Graft-Versus-Host Disease Development

A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis.

Hematopoietic Stem Cell Transplantation following Reduced Intensity Conditioning for High Risk Patients with Paroxysmal Nocturnal Hemoglobinuria

Membranous Glomerulonephritis and Nephrotic Syndrome as a Late Manifestation of Chronic Graft-Versus-Host Reaction Following Allogeneic Transplantation for Hematologic Malignancy.

Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Host Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin Confirm a Low Incidence of Graft Versus Host Disease (GVHD) and Retained Graft Anti-Tumor Activity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only